Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard - Stock Discussion Forum BioVaxys Technology Corp. C.BIOV

Alternate Symbol(s):  BVAXF

BioVaxys Technology Corp. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on improving patient lives with novel immunotherapies based on the DPX immune-educating technology platform and its HapTenix neoantigen tumor cell construct platform, for treating cancers, infectious disease, antigen desensitization and other immunological fields. The Company's clinical... see more

Bullboard (CSE:BIOV)

View:
Post by NewMexicatson Dec 05, 2024 11:55pm

Partnership & Licensing

The exact reason why the company has stated they are looking for licensing deals @ partnerships, and are only pursuing pre-clinicals and less costly Allergy desensitization.
Post by NewMexicatson Dec 05, 2024 11:54pm

Partnership & Licensing

The exact reason why the company has stated they are looking for licensing deals & partnerships, and are only pursuing pre-clinicals and less costly Allergy desensitization.
Post by mtgfree1on Dec 05, 2024 3:38pm

Just a play , look out

No point to say more in my view 
Post by frankmanon Dec 05, 2024 10:19am

I see my .06 bid on the order depth chart moving up/ L2 ord

I am going to enter a second bid for my trading shares (not many maybe 40k shares alltogether) closer to months end as tax loss season comes to an end. There should be a couple more news updates by ...more  
Post by frankmanon Dec 05, 2024 8:55am

Full news release

DPX Formulations Superior to Mixing with Commonly Used Adjuvants DPX Without Antigen Cargo Has Immune Stimulating Properties Unique Potential for DPX in New Fields of Use VANCOUVER, BC, Dec ...more  
Comment by Hideawayon Dec 03, 2024 4:00pm

RE:Recovery and Growth: $BIOV and $BOLT.CN

Without a partner with a big pharma and not a lot of cash,BIOV will have a difficult time conducting a clinical trial imo.
Post by frankmanon Dec 02, 2024 10:14am

50 percent minimum to 100 ~ percent to March 2025 L2 bid ask

Ask 0.085 30,000 4 0.08 24,000 4 0.075 48,000 5 0.07 52,000 5 0 ...more  
Post by frankmanon Dec 02, 2024 10:08am

Still expect a 50 percent increase in s/p to March 2025

Still haven’t bought my year-end trading shares with roughly 18 trading days left yet. Waiting to see how low I can steal. "Expect a 50% increase in stock price into March 2025 roughly a double ...more  
Post by frankmanon Nov 26, 2024 3:40pm

Level 2 bid ask 3:40

Ask 0.085 29,000 3 0.08 26,000 4 0.075 48,028 5 0.07 97,000 4 0 ...more  
Post by frankmanon Nov 26, 2024 2:23pm

Current bid ask level 2

Ask 0.085 29,000 3 0.08 26,000 4 0.075 47,000 4 0.07 97,000 4 0 ...more  
Post by frankmanon Nov 26, 2024 2:21pm

1 million shares CDN traded /OTC $US traded 1/2 mil

Sym-X Bid - Ask Last Chg %Ch Vol $Vol #Tr     ATS 217.0 0.06 · 0.065  ...more  
Post by frankmanon Nov 26, 2024 12:25pm

Wonder if CEO Passin will participate again in this pp

CEO Passin bought 6 million shares of a previous financing ($300k 09/11 news release).  He holds 19 mil~ shares. Current pp .07 with .15 warrants     “James Passin, chief executive ...more  
Post by frankmanon Nov 26, 2024 10:50am

Ooooh .06 can we see .04 or .03? Current bid and ask

As I said looking for some trading shares by year-end. Could we see .045 or lower please? Last time I picked up shares at .04 and .05. Ask 0.085 29,000 3  ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities